Loading...

Amerisourcebergen Corp
NYSE:ABC

Watchlist Manager
Amerisourcebergen Corp Logo
Amerisourcebergen Corp
NYSE:ABC
Watchlist
Price: 155.08 USD -1.12% Market Closed
Updated: Feb 6, 2023

Intrinsic Value

The intrinsic value of one ABC stock under the Base Case scenario is 354.99 USD. Compared to the current market price of 155.08 USD, Amerisourcebergen Corp is Undervalued by 56%.

The Intrinsic Value is calculated as the average of the two valuation methods:

ABC Intrinsic Value
Base Case
354.99 USD
Undervaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

ABC Profitability Score
Profitability Due Diligence

Amerisourcebergen Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score

Amerisourcebergen Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

ABC Solvency Score
Solvency Due Diligence

Amerisourcebergen Corp's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Liabilities
Long-Term Liabilities
Positive Net Debt
High Interest Coverage
67/100
Solvency
Score

Amerisourcebergen Corp's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
3%
Gross Margin
1%
Operating Margin
1%
Net Margin
1%
FCF Margin
11 535%
ROE
15%
ROIC
Other

ABC Capital Structure
Amerisourcebergen Corp

Market Capitalization 32B USD
Total Debt 4.6B USD
Minority Interest 283M USD
Preferred Equity 0 USD
Cash and Equivalents 3.4B USD
Short-Term Investments 0 USD
Enterprise Value 33.5B USD

Wall St
Price Targets

ABC Price Targets Summary
Amerisourcebergen Corp

Wall Street analysts forecast ABC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABC is 183.86 USD with a low forecast of 156.55 USD and a high forecast of 208.95 USD.

Lowest
Price Target
156.55 USD
1% Upside
Average
Price Target
183.86 USD
19% Upside
Highest
Price Target
208.95 USD
35% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

ABC Competitors
Amerisourcebergen Corp

ABC Suppliers & Customers
Amerisourcebergen Corp

Amerisourcebergen Corp has 54 key suppliers from 7 countries and 5 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Pharmaceuticals industry.

United States of America
42
United Parcel Service Inc
Logistics & Transportation
Bristol-Myers Squibb Co
Pharmaceuticals
Abbvie Inc
Biotechnology
Amneal Pharmaceuticals Inc
Pharmaceuticals
Elanco Animal Health Inc
Pharmaceuticals
Biohaven Pharmaceutical Holding Company Ltd
Biotechnology
O
Organon & Co
Pharmaceuticals
Pfizer Inc
Pharmaceuticals
Merck & Co Inc
Pharmaceuticals
Eli Lilly and Co
Pharmaceuticals
Lannett Company Inc
Pharmaceuticals
Informatica Inc
Technology
Gilead Sciences Inc
Biotechnology
Amgen Inc
Biotechnology
OptiNose Inc
Pharmaceuticals
Eagle Pharmaceuticals Inc
Biotechnology
Viatris Inc
Pharmaceuticals
Aerie Pharmaceuticals Inc
Pharmaceuticals
Omeros Corp
Pharmaceuticals
I
ImmuCell Corp
Biotechnology
Vanda Pharmaceuticals Inc
Biotechnology
Exelixis Inc
Biotechnology
Akebia Therapeutics Inc
Biotechnology
Rigel Pharmaceuticals Inc
Biotechnology
TherapeuticsMD Inc
Pharmaceuticals
EyePoint Pharmaceuticals Inc
Pharmaceuticals
A
Assertio Holdings Inc
Pharmaceuticals
A
ANI Pharmaceuticals Inc
Pharmaceuticals
P
Puma Biotechnology Inc
Biotechnology
A
Antares Pharma Inc
Pharmaceuticals
Acorda Therapeutics Inc
Biotechnology
Pacira Biosciences Inc
Pharmaceuticals
Supernus Pharmaceuticals Inc
Pharmaceuticals
Regeneron Pharmaceuticals Inc
Biotechnology
A
Amphastar Pharmaceuticals Inc
Pharmaceuticals
Omniq Corp
Technology
Eton Pharmaceuticals Inc
Pharmaceuticals
Qualys Inc
Technology
T
Teligent Inc (NEW JERSEY)
Pharmaceuticals
Seagen Inc
Biotechnology
R
RVL Pharmaceuticals PLC
Pharmaceuticals
Dexcom Inc
Health Care
Suppliers Map

Amerisourcebergen Corp has 8 key customers from 4 countries and 4 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Biotechnology industry.

Ownership

ABC Insider Trading
Buy and sell transactions by insiders

Amerisourcebergen Corp insiders have only sold shares in the past 12 months.

During the last 12 months Amerisourcebergen Corp insiders have not bought any shares, and sold 4B USD worth of shares. The last transaction was made on Feb 6, 2023 by Collis Steven H (Chairman, President & CEO), who sold 1.7M USD worth of ABC shares.

Sold
0-3
months
3B USD
6
3-6
months
8.4M USD
3
6-9
months
907M USD
3
9-12
months
14.7M USD
3
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
3B USD
N/A
-3B
6 Months
3.1B USD
N/A
-3.1B
9 Months
4B USD
N/A
-4B
12 Months
4B USD
N/A
-4B
Purchases
18
Sales
397
No transactions found
Why is insider trading important?

Shareholder Return

ABC Price
Amerisourcebergen Corp

1M 1M
-6%
6M 6M
+11%
1Y 1Y
+12%
3Y 3Y
+75%
5Y 5Y
+83%
Annual Price Range
155.08
52w Low
135.33
52w High
173.99
Price Metrics
Average Annual Return 13.55%
Standard Deviation of Annual Returns 23.36%
Max Drawdown -29%
Shares Statistics
Market Capitalization 32B USD
Shares Outstanding 202 440 992
Percentage of Shares Shorted 4.02%

Company Profile

Amerisourcebergen Corp

Country

United States of America

Industry

Health Care

Market Cap

32B USD

Dividend Yield

1.22%

Description

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. The company is headquartered in Conshohocken, Pennsylvania and currently employs 38,000 full-time employees. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty.

Contact

PENNSYLVANIA
Conshohocken
1 West First Avenue
+16107277000.0
https://www.amerisourcebergen.com/

IPO

1996-05-28

Employees

38 000

Officers

Chairman, Pres & CEO
Mr. Steven H. Collis
Exec. VP & CFO
Mr. James F. Cleary Jr.
Exec. VP & COO
Dr. Robert P. Mauch Ph.D., PharmD
Exec. VP and Chief Communications & Admin. Officer
Ms. Gina K. Clark
Exec. VP and Special Advisor to the Chairman & CEO
Mr. John G. Chou
Sr. VP, Chief Accounting Officer & Corp. Controller
Mr. Lazarus Krikorian
Show More
Sr. VP of Investor Relations
Bennett S. Murphy
Exec. VP & Chief Compliance Officer
Ms. Kathy H. Gaddes
Exec. VP & Chief Legal Officer
Ms. Elizabeth S. Campbell
Exec. VP & Chief HR Officer
Ms. Silvana Battaglia
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one ABC stock?

The intrinsic value of one ABC stock under the Base Case scenario is 354.99 USD.

Is ABC stock undervalued or overvalued?

Compared to the current market price of 155.08 USD, Amerisourcebergen Corp is Undervalued by 56%.